Is Synchrony SYFB stock worth buying today SYFB Latest Quarter Earnings Synchrony B preferred reports no EPS or revenue results How Tarsus Pharmaceuticals TARS differentiates itself from competitors Underperforming 20260511 State Street Industrial Select Sector SPDR ETF XLI NCZA Virtus releases quarterly preferred share earnings with no major surprises or unexpected shifts for fixed income investors Market Wrap Tech leads sector gains while consumer names lag amid slight market dips